Vanuatu

Vanuatu

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
5.16 (4.21 - 6.18) 2019 Modelled IHME
5.23 (4.23 - 6.25) 2018 Modelled IHME
5.36 (4.21 - 6.45) 2017 Modelled IHME
5.62 (4.44 - 6.76) 2016 Modelled IHME
5.88 (4.68 - 7.13) 2015 Modelled IHME
6.01 (4.85 - 7.21) 2014 Modelled IHME
6.12 (4.97 - 7.24) 2013 Modelled IHME
6.2 (5.07 - 7.36) 2012 Modelled IHME
6.29 (5.15 - 7.42) 2011 Modelled IHME
6.39 (5.17 - 7.59) 2010 Modelled IHME
6.53 (5.24 - 7.80) 2009 Modelled IHME
6.7 (5.33 - 8.04) 2008 Modelled IHME
6.87 (5.40 - 8.35) 2007 Modelled IHME
7.01 (5.40 - 8.64) 2006 Modelled IHME
7.08 (5.41 - 8.86) 2005 Modelled IHME
7.1 (5.43 - 8.76) 2004 Modelled IHME
7.1 (5.49 - 8.66) 2003 Modelled IHME
7.11 (5.49 - 8.60) 2002 Modelled IHME
7.11 (5.49 - 8.62) 2001 Modelled IHME
7.13 (5.49 - 8.68) 2000 Modelled IHME
7.25 (5.60 - 8.78) 1999 Modelled IHME
7.51 (5.78 - 9.13) 1998 Modelled IHME
7.82 (6 - 9.51) 1997 Modelled IHME
8.12 (6.22 - 9.90) 1996 Modelled IHME
8.32 (6.34 - 10.16) 1995 Modelled IHME
8.45 (6.52 - 10.26) 1994 Modelled IHME
8.57 (6.69 - 10.39) 1993 Modelled IHME
8.66 (6.81 - 10.50) 1992 Modelled IHME
8.74 (6.91 - 10.62) 1991 Modelled IHME
8.79 (6.97 - 10.71) 1990 Modelled IHME
13.31 (10.98 - 16.22) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
1.45 (0.96 - 1.95) 2019 Modelled IHME
1.42 (0.92 - 1.91) 2018 Modelled IHME
1.42 (0.89 - 1.98) 2017 Modelled IHME
1.49 (0.96 - 2.05) 2016 Modelled IHME
1.57 (1.03 - 2.17) 2015 Modelled IHME
1.56 (1.03 - 2.15) 2014 Modelled IHME
1.56 (1.03 - 2.12) 2013 Modelled IHME
1.55 (1.01 - 2.09) 2012 Modelled IHME
1.54 (1.01 - 2.07) 2011 Modelled IHME
1.54 (1 - 2.05) 2010 Modelled IHME
1.61 (1.04 - 2.14) 2009 Modelled IHME
1.79 (1.15 - 2.40) 2008 Modelled IHME
2 (1.28 - 2.71) 2007 Modelled IHME
2.17 (1.38 - 2.99) 2006 Modelled IHME
2.25 (1.42 - 3.11) 2005 Modelled IHME
2.14 (1.36 - 2.97) 2004 Modelled IHME
1.89 (1.18 - 2.62) 2003 Modelled IHME
1.59 (0.99 - 2.17) 2002 Modelled IHME
1.33 (0.84 - 1.82) 2001 Modelled IHME
1.23 (0.76 - 1.68) 2000 Modelled IHME
1.25 (0.79 - 1.69) 1999 Modelled IHME
1.32 (0.85 - 1.78) 1998 Modelled IHME
1.43 (0.94 - 1.93) 1997 Modelled IHME
1.58 (1.05 - 2.13) 1996 Modelled IHME
1.74 (1.18 - 2.37) 1995 Modelled IHME
2.05 (1.39 - 2.74) 1994 Modelled IHME
2.58 (1.75 - 3.43) 1993 Modelled IHME
3.28 (2.23 - 4.38) 1992 Modelled IHME
4.11 (2.76 - 5.49) 1991 Modelled IHME
5.02 (3.31 - 6.71) 1990 Modelled IHME
3 1998 Survey/reported WHO WPRO, Woodring J et al, 2017
8.48 (6.45 - 10.98) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
13,309 (10,556 - 16,217) 1990 Modelled IHME
13,546 (10,710 - 16,454) 1991 Modelled IHME
13,743 (10,807 - 16,648) 1992 Modelled IHME
13,905 (10,858 - 16,860) 1993 Modelled IHME
14,043 (10,836 - 17,050) 1994 Modelled IHME
14,165 (10,796 - 17,298) 1995 Modelled IHME
14,157 (10,839 - 17,271) 1996 Modelled IHME
13,974 (10,715 - 16,988) 1997 Modelled IHME
13,745 (10,583 - 16,709) 1998 Modelled IHME
13,615 (10,518 - 16,472) 1999 Modelled IHME
13,733 (10,575 - 16,703) 2000 Modelled IHME
14,052 (10,838 - 17,023) 2001 Modelled IHME
14,402 (11,115 - 17,424) 2002 Modelled IHME
14,767 (11,402 - 17,998) 2003 Modelled IHME
15,130 (11,582 - 18,682) 2004 Modelled IHME
15,474 (11,815 - 19,368) 2005 Modelled IHME
15,702 (12,100 - 19,343) 2006 Modelled IHME
15,772 (12,381 - 19,159) 2007 Modelled IHME
15,749 (12,520 - 18,898) 2008 Modelled IHME
15,704 (12,613 - 18,755) 2009 Modelled IHME
15,717 (12,712 - 18,677) 2010 Modelled IHME
15,813 (12,943 - 18,671) 2011 Modelled IHME
15,937 (13,036 - 18,906) 2012 Modelled IHME
16,050 (13,037 - 18,990) 2013 Modelled IHME
16,108 (13,002 - 19,301) 2014 Modelled IHME
16,066 (12,783 - 19,484) 2015 Modelled IHME
15,650 (12,371 - 18,831) 2016 Modelled IHME
15,224 (11,955 - 18,316) 2017 Modelled IHME
15,139 (12,248 - 18,079) 2018 Modelled IHME
15,194 (12,410 - 18,191) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
9.16 (6.05 - 12.70) 2019 Modelled IHME
9.23 (6.11 - 12.90) 2018 Modelled IHME
9.31 (6.22 - 13.20) 2017 Modelled IHME
9.35 (6.26 - 13.20) 2016 Modelled IHME
9.38 (6.22 - 13.30) 2015 Modelled IHME
9.32 (6.13 - 13.10) 2014 Modelled IHME
9.14 (6.05 - 13) 2013 Modelled IHME
8.94 (5.96 - 12.60) 2012 Modelled IHME
8.76 (5.82 - 12.30) 2011 Modelled IHME
8.55 (5.65 - 12.10) 2010 Modelled IHME
8.52 (5.66 - 12.10) 2009 Modelled IHME
8.52 (5.68 - 12.20) 2008 Modelled IHME
8.47 (5.69 - 12) 2007 Modelled IHME
8.36 (5.61 - 11.90) 2006 Modelled IHME
8.34 (5.56 - 11.70) 2005 Modelled IHME
8.28 (5.54 - 11.80) 2004 Modelled IHME
8.6 (5.76 - 12.40) 2003 Modelled IHME
9.25 (6.25 - 13.10) 2002 Modelled IHME
10.1 (6.93 - 14.10) 2001 Modelled IHME
10.2 (7.14 - 14.20) 2000 Modelled IHME
10.6 (7.33 - 14.70) 1999 Modelled IHME
10.6 (7.39 - 14.70) 1998 Modelled IHME
10.7 (7.37 - 14.70) 1997 Modelled IHME
10.7 (7.42 - 14.80) 1996 Modelled IHME
10.7 (7.52 - 14.80) 1995 Modelled IHME
11 (7.74 - 15.10) 1994 Modelled IHME
10.9 (7.61 - 15) 1993 Modelled IHME
11.1 (7.76 - 15.40) 1992 Modelled IHME
11.1 (7.64 - 15.50) 1991 Modelled IHME
11.1 (7.59 - 16) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
27 (18 - 38) 2019 Modelled IHME
27 (18 - 37) 2018 Modelled IHME
26 (18 - 37) 2017 Modelled IHME
26 (17 - 37) 2016 Modelled IHME
26 (17 - 36) 2015 Modelled IHME
25 (16 - 35) 2014 Modelled IHME
24 (16 - 34) 2013 Modelled IHME
23 (15 - 32) 2012 Modelled IHME
22 (15 - 31) 2011 Modelled IHME
21 (14 - 30) 2010 Modelled IHME
20 (14 - 29) 2009 Modelled IHME
20 (13 - 29) 2008 Modelled IHME
19 (13 - 28) 2007 Modelled IHME
19 (13 - 27) 2006 Modelled IHME
18 (12 - 26) 2005 Modelled IHME
18 (12 - 25) 2004 Modelled IHME
18 (12 - 26) 2003 Modelled IHME
19 (13 - 27) 2002 Modelled IHME
20 (14 - 28) 2001 Modelled IHME
20 (14 - 27) 2000 Modelled IHME
20 (14 - 28) 1999 Modelled IHME
19 (14 - 27) 1998 Modelled IHME
19 (13 - 26) 1997 Modelled IHME
19 (13 - 26) 1996 Modelled IHME
18 (13 - 25) 1995 Modelled IHME
18 (13 - 25) 1994 Modelled IHME
18 (12 - 24) 1993 Modelled IHME
18 (12 - 24) 1992 Modelled IHME
17 (12 - 24) 1991 Modelled IHME
17 (11 - 24) 1990 Modelled IHME
29 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
56 (47 - 65) 2019 Modelled IHME
56 (47 - 66) 2018 Modelled IHME
56 (47 - 66) 2017 Modelled IHME
56 (47 - 66) 2016 Modelled IHME
57 (47 - 66) 2015 Modelled IHME
57 (48 - 66) 2014 Modelled IHME
57 (48 - 66) 2013 Modelled IHME
56 (47 - 66) 2012 Modelled IHME
56 (47 - 66) 2011 Modelled IHME
56 (47 - 66) 2010 Modelled IHME
56 (48 - 66) 2009 Modelled IHME
57 (48 - 66) 2008 Modelled IHME
57 (48 - 66) 2007 Modelled IHME
57 (48 - 66) 2006 Modelled IHME
57 (48 - 66) 2005 Modelled IHME
57 (49 - 66) 2004 Modelled IHME
58 (49 - 67) 2003 Modelled IHME
58 (49 - 67) 2002 Modelled IHME
58 (49 - 67) 2001 Modelled IHME
58 (49 - 67) 2000 Modelled IHME
58 (49 - 67) 1999 Modelled IHME
58 (49 - 68) 1998 Modelled IHME
58 (49 - 67) 1997 Modelled IHME
58 (49 - 67) 1996 Modelled IHME
58 (49 - 67) 1995 Modelled IHME
58 (49 - 67) 1994 Modelled IHME
58 (49 - 67) 1993 Modelled IHME
58 (49 - 67) 1992 Modelled IHME
58 (49 - 67) 1991 Modelled IHME
58 (49 - 67) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
80 2018 Survey/reported WHO/UNICEF
75 2017 Survey/reported WHO/UNICEF
82 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
85 2018 Survey/reported WHO/UNICEF
85 2017 Survey/reported WHO/UNICEF
81 2016 Survey/reported WHO/UNICEF
80 2015 Survey/reported WHO/UNICEF
86 2014 Survey/reported WHO/UNICEF
83 2013 Survey/reported WHO/UNICEF
79 2012 Survey/reported WHO/UNICEF
76 2011 Survey/reported WHO/UNICEF
73 2010 Survey/reported WHO/UNICEF
69 2009 Survey/reported WHO/UNICEF
66 2008 Survey/reported WHO/UNICEF
62 2007 Survey/reported WHO/UNICEF
59 2006 Survey/reported WHO/UNICEF
61 2005 Survey/reported WHO/UNICEF
63 2004 Survey/reported WHO/UNICEF
64 2003 Survey/reported WHO/UNICEF
66 2002 Survey/reported WHO/UNICEF
68 2001 Survey/reported WHO/UNICEF
70 2000 Survey/reported WHO/UNICEF
71 1999 Survey/reported WHO/UNICEF
73 1998 Survey/reported WHO/UNICEF
75 1997 Survey/reported WHO/UNICEF
69 1996 Survey/reported WHO/UNICEF
66 1995 Survey/reported WHO/UNICEF
69 1994 Survey/reported WHO/UNICEF
82 1993 Survey/reported WHO/UNICEF
82 1992 Survey/reported WHO/UNICEF
46 1991 Survey/reported WHO/UNICEF
90 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HBV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.61 (0.48 - 0.76) 2019 Modelled IHME
0.61 (0.48 - 0.76) 2018 Modelled IHME
0.61 (0.48 - 0.76) 2017 Modelled IHME
0.61 (0.48 - 0.75) 2016 Modelled IHME
0.61 (0.48 - 0.76) 2015 Modelled IHME
0.61 (0.49 - 0.76) 2014 Modelled IHME
0.62 (0.49 - 0.76) 2013 Modelled IHME
0.62 (0.49 - 0.77) 2012 Modelled IHME
0.62 (0.49 - 0.77) 2011 Modelled IHME
0.62 (0.50 - 0.77) 2010 Modelled IHME
0.63 (0.50 - 0.78) 2009 Modelled IHME
0.63 (0.50 - 0.78) 2008 Modelled IHME
0.63 (0.50 - 0.79) 2007 Modelled IHME
0.64 (0.50 - 0.79) 2006 Modelled IHME
0.64 (0.50 - 0.80) 2005 Modelled IHME
0.64 (0.51 - 0.80) 2004 Modelled IHME
0.64 (0.51 - 0.80) 2003 Modelled IHME
0.64 (0.51 - 0.80) 2002 Modelled IHME
0.64 (0.51 - 0.80) 2001 Modelled IHME
0.64 (0.51 - 0.80) 2000 Modelled IHME
0.65 (0.51 - 0.81) 1999 Modelled IHME
0.65 (0.51 - 0.82) 1998 Modelled IHME
0.66 (0.51 - 0.82) 1997 Modelled IHME
0.66 (0.52 - 0.83) 1996 Modelled IHME
0.66 (0.52 - 0.84) 1995 Modelled IHME
0.66 (0.52 - 0.84) 1994 Modelled IHME
0.66 (0.52 - 0.83) 1993 Modelled IHME
0.66 (0.52 - 0.83) 1992 Modelled IHME
0.66 (0.52 - 0.83) 1991 Modelled IHME
0.66 (0.52 - 0.83) 1990 Modelled IHME
Showing out of
Show more

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
1,004 (783 - 1,256) 1990 Modelled IHME
1,027 (802 - 1,289) 1991 Modelled IHME
1,051 (821 - 1,320) 1992 Modelled IHME
1,075 (842 - 1,353) 1993 Modelled IHME
1,100 (862 - 1,392) 1994 Modelled IHME
1,125 (881 - 1,424) 1995 Modelled IHME
1,149 (904 - 1,447) 1996 Modelled IHME
1,170 (919 - 1,468) 1997 Modelled IHME
1,191 (937 - 1,494) 1998 Modelled IHME
1,214 (957 - 1,517) 1999 Modelled IHME
1,241 (979 - 1,548) 2000 Modelled IHME
1,271 (1,002 - 1,586) 2001 Modelled IHME
1,302 (1,027 - 1,623) 2002 Modelled IHME
1,334 (1,054 - 1,659) 2003 Modelled IHME
1,367 (1,080 - 1,701) 2004 Modelled IHME
1,399 (1,102 - 1,744) 2005 Modelled IHME
1,429 (1,127 - 1,775) 2006 Modelled IHME
1,456 (1,152 - 1,803) 2007 Modelled IHME
1,482 (1,173 - 1,837) 2008 Modelled IHME
1,508 (1,200 - 1,869) 2009 Modelled IHME
1,534 (1,218 - 1,901) 2010 Modelled IHME
1,562 (1,238 - 1,941) 2011 Modelled IHME
1,590 (1,262 - 1,970) 2012 Modelled IHME
1,618 (1,288 - 2,000) 2013 Modelled IHME
1,646 (1,306 - 2,032) 2014 Modelled IHME
1,672 (1,323 - 2,073) 2015 Modelled IHME
1,696 (1,344 - 2,092) 2016 Modelled IHME
1,722 (1,361 - 2,144) 2017 Modelled IHME
1,757 (1,399 - 2,187) 2018 Modelled IHME
1,799 (1,427 - 2,236) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
5.21 (3.04 - 7.77) 2019 Modelled IHME
5.16 (3 - 7.72) 2018 Modelled IHME
5.12 (2.98 - 7.63) 2017 Modelled IHME
5.07 (2.97 - 7.51) 2016 Modelled IHME
5.04 (2.96 - 7.50) 2015 Modelled IHME
5.05 (3.01 - 7.62) 2014 Modelled IHME
5.07 (2.95 - 7.68) 2013 Modelled IHME
5.1 (3.01 - 7.77) 2012 Modelled IHME
5.12 (3.01 - 7.84) 2011 Modelled IHME
5.06 (2.96 - 7.79) 2010 Modelled IHME
5.03 (2.94 - 7.77) 2009 Modelled IHME
5.02 (2.98 - 7.69) 2008 Modelled IHME
4.95 (2.95 - 7.65) 2007 Modelled IHME
4.84 (2.95 - 7.54) 2006 Modelled IHME
4.78 (2.92 - 7.41) 2005 Modelled IHME
4.58 (2.78 - 7.02) 2004 Modelled IHME
4.48 (2.70 - 6.84) 2003 Modelled IHME
4.52 (2.81 - 6.78) 2002 Modelled IHME
4.68 (2.97 - 7.04) 2001 Modelled IHME
4.67 (2.94 - 6.99) 2000 Modelled IHME
4.86 (3.11 - 7.26) 1999 Modelled IHME
4.88 (3.13 - 7.26) 1998 Modelled IHME
4.93 (3.18 - 7.39) 1997 Modelled IHME
4.99 (3.23 - 7.39) 1996 Modelled IHME
4.98 (3.24 - 7.44) 1995 Modelled IHME
5.09 (3.32 - 7.61) 1994 Modelled IHME
5 (3.24 - 7.45) 1993 Modelled IHME
5 (3.26 - 7.36) 1992 Modelled IHME
4.91 (3.19 - 7.20) 1991 Modelled IHME
4.77 (3.09 - 6.98) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
15 (9 - 23) 2019 Modelled IHME
15 (9 - 22) 2018 Modelled IHME
15 (8 - 22) 2017 Modelled IHME
14 (8 - 21) 2016 Modelled IHME
14 (8 - 20) 2015 Modelled IHME
14 (8 - 20) 2014 Modelled IHME
13 (8 - 20) 2013 Modelled IHME
13 (8 - 20) 2012 Modelled IHME
13 (8 - 20) 2011 Modelled IHME
12 (7 - 19) 2010 Modelled IHME
12 (7 - 19) 2009 Modelled IHME
12 (7 - 18) 2008 Modelled IHME
11 (7 - 18) 2007 Modelled IHME
11 (7 - 17) 2006 Modelled IHME
10 (6 - 16) 2005 Modelled IHME
10 (6 - 15) 2004 Modelled IHME
9 (6 - 14) 2003 Modelled IHME
9 (6 - 14) 2002 Modelled IHME
9 (6 - 14) 2001 Modelled IHME
9 (6 - 13) 2000 Modelled IHME
9 (6 - 14) 1999 Modelled IHME
9 (6 - 13) 1998 Modelled IHME
9 (6 - 13) 1997 Modelled IHME
9 (6 - 13) 1996 Modelled IHME
8 (6 - 13) 1995 Modelled IHME
8 (6 - 13) 1994 Modelled IHME
8 (5 - 12) 1993 Modelled IHME
8 (5 - 12) 1992 Modelled IHME
8 (5 - 11) 1991 Modelled IHME
7 (5 - 11) 1990 Modelled IHME
2 2016 Modelled WHO
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
19 (13 - 27) 2019 Modelled IHME
19 (13 - 26) 2018 Modelled IHME
19 (13 - 26) 2017 Modelled IHME
19 (13 - 26) 2016 Modelled IHME
19 (12 - 26) 2015 Modelled IHME
19 (12 - 26) 2014 Modelled IHME
19 (12 - 26) 2013 Modelled IHME
19 (13 - 26) 2012 Modelled IHME
19 (13 - 26) 2011 Modelled IHME
19 (13 - 26) 2010 Modelled IHME
19 (13 - 26) 2009 Modelled IHME
19 (13 - 26) 2008 Modelled IHME
19 (13 - 26) 2007 Modelled IHME
19 (13 - 26) 2006 Modelled IHME
19 (13 - 26) 2005 Modelled IHME
19 (13 - 26) 2004 Modelled IHME
19 (13 - 25) 2003 Modelled IHME
19 (13 - 25) 2002 Modelled IHME
19 (13 - 25) 2001 Modelled IHME
19 (13 - 25) 2000 Modelled IHME
19 (13 - 26) 1999 Modelled IHME
19 (13 - 26) 1998 Modelled IHME
19 (13 - 26) 1997 Modelled IHME
19 (13 - 26) 1996 Modelled IHME
19 (13 - 26) 1995 Modelled IHME
19 (13 - 26) 1994 Modelled IHME
19 (13 - 26) 1993 Modelled IHME
19 (13 - 26) 1992 Modelled IHME
19 (13 - 26) 1991 Modelled IHME
19 (13 - 26) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016
Technical notes

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
HBV elimination goal
HBV National Action Plan
HepB birth dose policy
Yes
Year of birth dose introduction
1998
Eligible for HBV generic medicines
HBV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
No
At least one opioid substitution therapy (OST) program operational
No
NSP in at least one prison
No
OST in at least one prison
No
% of substance use disorder facilities offering hepatitis testing
None
% of substance use disorder facilities offering hepatitis treatment
None

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
27
2019
(18 - 38)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
15
2019
(9 - 23)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
82 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Partners